Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$927M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$430M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$382M |
| 5 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
+$306M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$507M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$430M |
| 4 |
iShares Russell Mid-Cap ETF
IWR
|
+$356M |
| 5 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.75% |
| 2 | Healthcare | 8.81% |
| 3 | Financials | 8.45% |
| 4 | Consumer Discretionary | 7.56% |
| 5 | Industrials | 7.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4001
Pathward Financial
CASH
$1.81B
| $1.11M | ﹤0.01% |
21,081
+3,381
| +19% | +$168K |
|
4002
SelectQuote
SLQT
$123M
| $1.11M | ﹤0.01% |
85,545
-108,337
| -56% | -$1.63M |
|
|
SAFE
4003
DELISTED
Safehold Inc.
SAFE
| $1.11M | ﹤0.01% |
15,398
+550
| +4% | +$46.6K |
|
4004
Liquidity Services
LQDT
$1.28B
| $1.1M | ﹤0.01% |
51,044
+5,491
| +12% | +$125K |
|
4005
Pitney Bowes
PBI
$2.33B
| $1.1M | ﹤0.01% |
153,104
-18,907
| -11% | -$148K |
|
4006
Marten Transport
MRTN
$1.2B
| $1.1M | ﹤0.01% |
70,219
-7,089
| -9% | -$111K |
|
4007
United States 12 Month Natural Gas Fund
UNL
$13.5M
| $1.1M | ﹤0.01% |
75,866
+11,247
| +17% | +$131K |
|
|
HEQ
4008
John Hancock Hedged Equity & Income Fund
HEQ
$141M
| $1.1M | ﹤0.01% |
87,570
+14,056
| +19% | +$187K |
|
4009
Utah Medical Products
UTMD
$227M
| $1.1M | ﹤0.01% |
11,840
+6,250
| +112% | +$552K |
|
|
VLRS
4010
Controladora Vuela Compania de Aviacion
VLRS
$927M
| $1.1M | ﹤0.01% |
50,292
+48,642
| +2,948% | +$1.02M |
|
|
TMPM
4011
DELISTED
Turmeric Acquisition Corp. Class A Ordinary Shares
TMPM
| $1.09M | ﹤0.01% |
111,885
-10,000
| -8% | -$97.6K |
|
|
EMO
4012
ClearBridge Energy Midstream Opportunity Fund
EMO
$1.04B
| $1.09M | ﹤0.01% |
50,044
-9,016
| -15% | -$193K |
|
4013
First Advantage
FA
$4.05B
| $1.09M | ﹤0.01% |
57,380
+8,000
| +16% | +$168K |
|
4014
PUT
GDS Holdings
GDS
$6.29B
| $1.09M | ﹤0.01% |
+19,300
| New | +$1.19M |
|
4015
Celldex Therapeutics
CLDX
$3.37B
| $1.09M | ﹤0.01% |
20,185
+20,036
| +13,447% | +$940K |
|
4016
PUT
Editas Medicine
EDIT
$432M
| $1.09M | ﹤0.01% |
+26,500
| New | +$1.45M |
|
4017
Old Second Bancorp
OSBC
$1.29B
| $1.09M | ﹤0.01% |
83,084
+13,924
| +20% | +$167K |
|
|
JSD
4018
DELISTED
NUVEEN SHORT DURATION CREDIT OPPORTUNITIES FUND
JSD
| $1.09M | ﹤0.01% |
71,972
-2,310
| -3% | -$34.1K |
|
|
NEX
4019
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $1.08M | ﹤0.01% |
235,787
+156,081
| +196% | +$628K |
|
4020
Nuveen Mortgage and Income Fund
JLS
$94.9M
| $1.08M | ﹤0.01% |
52,002
-5,042
| -9% | -$106K |
|
4021
Park-Ohio Holdings
PKOH
$693M
| $1.08M | ﹤0.01% |
42,297
+19,217
| +83% | +$522K |
|
4022
Invesco S&P MidCap 400 Pure Value ETF
RFV
$338M
| $1.08M | ﹤0.01% |
11,852
-224
| -2% | -$20.6K |
|
4023
Barrett Business Services
BBSI
$783M
| $1.08M | ﹤0.01% |
56,560
+16,788
| +42% | +$314K |
|
4024
eGain
EGAN
$203M
| $1.08M | ﹤0.01% |
105,630
+72,192
| +216% | +$816K |
|
|
EVA
4025
DELISTED
Enviva Inc.
EVA
| $1.07M | ﹤0.01% |
19,805
-475
| -2% | -$25.5K |
|
Similar funds
Wells Fargo's Q3 2021 Portfolio in Review
As of Q3 2021, Wells Fargo held 8,005 positions worth $455B, down 0.26% from $456B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Wells Fargo's Q3 2021 filing shows 478 new, 3,039 increased, 3,074 reduced and 321 closed positions. Its largest new stake was Blend Labs: 6,286,123 shares worth $84.7M. The largest sale was iShares Russell 2000 ETF, an estimated $1.03B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- Wells Fargo's largest Q3 2021 buy was Blend Labs: 6,286,123 shares worth $84.7M.
- Wells Fargo added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $1.04B increase.
- Wells Fargo's biggest Q3 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $1.03B.
- Wells Fargo fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $166M.
- Wells Fargo's ten largest holdings make up 16% of its $455B portfolio in Q3 2021.
- Wells Fargo opened 478 new positions and closed 321 in Q3 2021.
- Wells Fargo's portfolio value fell 0.26% quarter-over-quarter to $455B.
Based on Wells Fargo's 13F filing for Q3 2021, filed 15 Nov 2021.